Today: 21 May 2026
BlueScope Steel stock jumps 21% on A$30 takeover bid — the next catalyst investors are watching

BlueScope Steel stock jumps 21% on A$30 takeover bid — the next catalyst investors are watching

SYDNEY, Jan 6, 2026, 16:58 AEDT — Market closed

  • BlueScope Steel shares closed up 20.6% at A$29.48 after SGH and Steel Dynamics put forward a non-binding A$30-a-share takeover approach.
  • BlueScope said the proposal is conditional on exclusivity and due diligence, among other hurdles, and the board is weighing it against “fundamental value”.
  • Attention now shifts to any update on due diligence access and BlueScope’s half-year results on Feb. 16.

BlueScope Steel Limited (ASX:BSL) shares closed up 20.57% at A$29.48 on Tuesday after Australian conglomerate SGH and U.S. steelmaker Steel Dynamics confirmed an approach to buy the company for A$30 a share in cash.

The move pulled the stock to within about 1.7% of the indicative price, leaving traders to price the risk that talks fail — and the chance the bidders lift their offer. The last close before the rally was A$24.45.

The timing matters because BlueScope has been arguing its cash flow and earnings power are set to improve as capital spending peaks and cost initiatives flow through, even as steel demand remains sensitive to tariff uncertainty and order patterns.

BlueScope said it received the unsolicited “non-binding” proposal on Dec. 12 and that it would be pursued via a scheme of arrangement — a court-supervised takeover structure that typically requires a shareholder vote. Under the proposed carve-up, SGH would acquire all shares and then on-sell BlueScope’s North American businesses to Steel Dynamics. BlueScope+1

In their joint statement, SGH and Steel Dynamics put the proposal’s equity value at about A$13.2 billion ($8.8 billion). They said the A$30 price would be adjusted down for any cash dividends paid after Dec. 12.

BlueScope said the proposal comes with a long list of conditions, including exclusivity and due diligence — the bidder’s detailed review of a company’s books — as well as a “no material adverse change” clause, meaning no major deterioration in the business before a deal completes. It also cited a requirement for unanimous board support, shareholder and regulatory approvals, and noted the proposal includes “highly conditional” debt funding support. BlueScope

The company disclosed it had previously rejected three unsolicited approaches, including offers of A$27.50 and A$29 per share in late 2024, and a different structure in early 2025. BlueScope said those proposals materially undervalued the company and carried significant execution risk around regulatory outcomes.

Mark Gardner, chief executive at MPC Markets, called the latest approach “value-unlocking” but “highly conditional.” BlueScope traded between A$28.11 and A$29.86 on Tuesday, with about 4.78 million shares changing hands, while the S&P/ASX 200 index fell 0.52%. Reuters+2Investing.com+2

A key risk for holders is that the proposal is not binding, and the conditions give both sides multiple off-ramps. If BlueScope refuses exclusivity, if due diligence throws up issues, or if financing and regulatory approvals prove harder than expected, the stock could retrace toward pre-bid levels.

Stock Market Today

  • Why Investors Should Sell Rapid7 Amid Declining Metrics and Consider Alternatives
    May 21, 2026, 3:54 PM EDT. Rapid7 (RPD) shares have plunged nearly 50% since November 2025, raising concerns among investors. Key red flags include stagnant billings at $199.2 million, indicating customer acquisition struggles amid stiff competition. The firm's customer acquisition cost (CAC) payback period turned negative this quarter, suggesting sales efforts are not recouping expenses efficiently. Additionally, Rapid7's GAAP operating margin shrank by 1.7 percentage points over two years to 1.3%, questioning profitability despite revenue growth. Trading at 0.5× forward price-to-sales, the stock appears cheap but poses significant downside risks given weak fundamentals. Analysts advise caution and suggest considering higher quality alternatives before investing in Rapid7.

Latest articles

RBC Stock Heads Toward Earnings With Tougher Weeks Ahead

RBC Stock Heads Toward Earnings With Tougher Weeks Ahead

21 May 2026
Royal Bank of Canada shares climbed 1.46% to C$261.09 in Toronto Thursday, outpacing the S&P/TSX Composite ahead of its May 28 earnings release. Visible Alpha estimates see net income up 19% to C$5.4 billion. Analyst calls diverged, with BofA raising its price target and Raymond James downgrading the stock to neutral. RBC shares have gained nearly 49% over the past year.
Sandisk Stock Jumps Again as AI Demand Fuels Memory Squeeze

Sandisk Stock Jumps Again as AI Demand Fuels Memory Squeeze

21 May 2026
Sandisk shares surged about 10% Thursday, trading at $1,533.00 by 2:52 p.m. EDT after management said NAND flash supply would stay tight. Citi raised its price target to $2,025. Western Digital and Micron also gained. Sandisk reported fiscal Q3 revenue of $5.95 billion, up 97% sequentially, with net income of $3.62 billion.
Spotify jumps after Universal AI deal, 2030 outlook

Spotify jumps after Universal AI deal, 2030 outlook

21 May 2026
Spotify shares rose 13.5% to $491.92 Thursday after announcing a new AI music licensing deal with Universal Music Group and unveiling growth targets at its investor day in New York. The company projected mid-teens annual revenue growth through 2030, gross margin of 35–40%, and operating margin above 20%. Spotify reported 761 million monthly active users in April.
AbbVie stock slides 4% as pharma lags Wall Street rally — what investors watch next for ABBV
Previous Story

AbbVie stock slides 4% as pharma lags Wall Street rally — what investors watch next for ABBV

Why Commonwealth Bank (ASX:CBA) shares fell 3% as Australia’s CPI test nears
Next Story

Why Commonwealth Bank (ASX:CBA) shares fell 3% as Australia’s CPI test nears

Go toTop